Boanmycin overcomes bortezomib resistance by inducing DNA damage and endoplasmic reticulum functional impairment in multiple myeloma.

Our findings indicated that the body weights of the mice that were administered boanmycin were generally lower than those of the vehicle-treated groups, although this difference did not reach statistical significance (Fig. 6 E; Supplementary Fig. 3 D).

also in 111,027 other papers